乳腺癌脑转移的治疗

本发明涉及用于同时、分开或顺次施用以治疗乳腺癌脑转移的药物组合，其包含(a)磷脂酰肌醇3激酶抑制剂或其可药用盐，和(b)Her3拮抗剂；治疗患有乳腺癌脑转移的个体的方法，其包括对有需要的个体施用该组合；这种组合在治疗乳腺癌脑转移中的用途；及包含这种组合的商业包装。 The present invention relates to a pharmaceutical combination which comprises (a) a phosphatidylinositol 3-kinase inhibitor or pharmaceutically acceptable salt thereof...

Full description

Saved in:
Bibliographic Details
Format Patent
LanguageChinese
Published 21.01.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:本发明涉及用于同时、分开或顺次施用以治疗乳腺癌脑转移的药物组合，其包含(a)磷脂酰肌醇3激酶抑制剂或其可药用盐，和(b)Her3拮抗剂；治疗患有乳腺癌脑转移的个体的方法，其包括对有需要的个体施用该组合；这种组合在治疗乳腺癌脑转移中的用途；及包含这种组合的商业包装。 The present invention relates to a pharmaceutical combination which comprises (a) a phosphatidylinositol 3-kinase inhibitor or pharmaceutically acceptable salt thereof, and (b) a Her3 antagonist, for simultaneous, separate or sequential administration for the treatment of breast cancer brain metastases; a method of treating a subject having a breast cancer brain metastases comprising administration of said combination to a subject in need thereof; use of such combination for the treatment of breast cancer brain metastases; and a commercial package comprising such combination.
Bibliography:Application Number: CN201580075191